IN150226B - - Google Patents

Info

Publication number
IN150226B
IN150226B IN21/CAL/79A IN31CA1979A IN150226B IN 150226 B IN150226 B IN 150226B IN 31CA1979 A IN31CA1979 A IN 31CA1979A IN 150226 B IN150226 B IN 150226B
Authority
IN
India
Application number
IN21/CAL/79A
Other languages
English (en)
Inventor
M Thominet
J Acher
J Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Priority to IN335/CAL/82A priority Critical patent/IN157591B/en
Publication of IN150226B publication Critical patent/IN150226B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
IN21/CAL/79A 1978-01-20 1979-01-11 IN150226B (US06373033-20020416-M00035.png)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN335/CAL/82A IN157591B (US06373033-20020416-M00035.png) 1978-01-20 1982-03-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
IN150226B true IN150226B (US06373033-20020416-M00035.png) 1982-08-21

Family

ID=9203689

Family Applications (1)

Application Number Title Priority Date Filing Date
IN21/CAL/79A IN150226B (US06373033-20020416-M00035.png) 1978-01-20 1979-01-11

Country Status (42)

Country Link
US (2) US4294828A (US06373033-20020416-M00035.png)
JP (1) JPS6049192B2 (US06373033-20020416-M00035.png)
AR (2) AR221354A1 (US06373033-20020416-M00035.png)
AT (1) AT377977B (US06373033-20020416-M00035.png)
AU (1) AU528561B2 (US06373033-20020416-M00035.png)
BE (1) BE872585A (US06373033-20020416-M00035.png)
BG (2) BG31497A3 (US06373033-20020416-M00035.png)
CA (1) CA1101430A (US06373033-20020416-M00035.png)
CH (1) CH637927A5 (US06373033-20020416-M00035.png)
CS (1) CS226181B2 (US06373033-20020416-M00035.png)
CY (1) CY1201A (US06373033-20020416-M00035.png)
DD (1) DD141520A5 (US06373033-20020416-M00035.png)
DE (1) DE2901181C2 (US06373033-20020416-M00035.png)
DK (1) DK158346C (US06373033-20020416-M00035.png)
EG (1) EG14045A (US06373033-20020416-M00035.png)
ES (2) ES476755A1 (US06373033-20020416-M00035.png)
FI (1) FI71126C (US06373033-20020416-M00035.png)
FR (1) FR2415099A1 (US06373033-20020416-M00035.png)
GB (2) GB2012765B (US06373033-20020416-M00035.png)
GR (1) GR64431B (US06373033-20020416-M00035.png)
HK (1) HK12184A (US06373033-20020416-M00035.png)
HU (1) HU179793B (US06373033-20020416-M00035.png)
IE (1) IE47798B1 (US06373033-20020416-M00035.png)
IL (1) IL56411A (US06373033-20020416-M00035.png)
IN (1) IN150226B (US06373033-20020416-M00035.png)
IT (1) IT1164655B (US06373033-20020416-M00035.png)
LU (1) LU80786A1 (US06373033-20020416-M00035.png)
MC (1) MC1232A1 (US06373033-20020416-M00035.png)
MX (2) MX5793E (US06373033-20020416-M00035.png)
NL (1) NL191707C (US06373033-20020416-M00035.png)
NO (1) NO151320C (US06373033-20020416-M00035.png)
NZ (1) NZ189378A (US06373033-20020416-M00035.png)
OA (1) OA06156A (US06373033-20020416-M00035.png)
PH (2) PH15725A (US06373033-20020416-M00035.png)
PL (2) PL118151B1 (US06373033-20020416-M00035.png)
PT (1) PT69068A (US06373033-20020416-M00035.png)
RO (2) RO76393A (US06373033-20020416-M00035.png)
SE (2) SE448874B (US06373033-20020416-M00035.png)
SU (1) SU820659A3 (US06373033-20020416-M00035.png)
YU (2) YU42172B (US06373033-20020416-M00035.png)
ZA (1) ZA79219B (US06373033-20020416-M00035.png)
ZM (1) ZM579A1 (US06373033-20020416-M00035.png)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
JP2007537232A (ja) * 2004-05-11 2007-12-20 ファイザー・プロダクツ・インク 非定型抗精神病薬と5−ht1b受容体拮抗薬の組合せ
PE20061318A1 (es) * 2005-04-22 2006-12-28 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
WO2009156889A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
WO2011158084A1 (en) 2010-06-17 2011-12-22 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
BR112019010127A2 (pt) * 2016-11-28 2019-08-20 Lb Pharmaceuticals Inc agentes psicotrópicos e usos dos mesmos
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
JP7268026B2 (ja) 2017-12-05 2023-05-02 サノビオン ファーマシューティカルズ インク 非ラセミ混合物およびその使用
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (US06373033-20020416-M00035.png) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
IE42210B1 (en) * 1974-12-18 1980-06-18 Synthelabo 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
OA06156A (fr) 1981-06-30
HU179793B (en) 1982-12-28
NO151320C (no) 1985-04-17
MX5793E (es) 1984-07-19
US4401822A (en) 1983-08-30
JPS54145658A (en) 1979-11-14
PL116532B1 (en) 1981-06-30
AU4337379A (en) 1979-07-26
CY1201A (en) 1983-12-31
DD141520A5 (de) 1980-05-07
IL56411A (en) 1982-09-30
AU528561B2 (en) 1983-05-05
IT7947706A0 (it) 1979-01-18
RO76393A (ro) 1981-03-30
CA1101430A (en) 1981-05-19
DK20979A (da) 1979-07-21
ZM579A1 (en) 1979-12-21
IT1164655B (it) 1987-04-15
FI71126C (fi) 1986-11-24
NL191707B (nl) 1995-12-01
SE8603773L (sv) 1986-09-09
PT69068A (fr) 1979-02-01
CS226181B2 (en) 1984-03-19
NO790180L (no) 1979-07-23
FI71126B (fi) 1986-08-14
PL118151B1 (en) 1981-09-30
BG31496A3 (en) 1982-01-15
SE448874B (sv) 1987-03-23
ATA39879A (de) 1983-12-15
NL7900457A (nl) 1979-07-24
DK158346C (da) 1990-10-08
SE460968B (sv) 1989-12-11
EG14045A (en) 1983-09-30
SE8603773D0 (sv) 1986-09-09
GB2083458B (en) 1983-03-09
PH15725A (en) 1983-03-18
US4294828A (en) 1981-10-13
DE2901181C2 (de) 1984-07-19
AR221354A1 (es) 1981-01-30
YU42172B (en) 1988-06-30
NO151320B (no) 1984-12-10
MX7623E (es) 1990-03-27
YU41278B (en) 1986-12-31
AR220574A1 (es) 1980-11-14
GR64431B (en) 1980-03-21
YU25483A (en) 1983-10-31
ZA79219B (en) 1980-01-30
YU5079A (en) 1983-06-30
NZ189378A (en) 1983-03-15
PH22287A (en) 1988-07-22
SE7900380L (sv) 1979-07-21
RO80311A (ro) 1982-12-06
BE872585A (fr) 1979-06-07
SU820659A3 (ru) 1981-04-07
IL56411A0 (en) 1979-03-12
FR2415099B1 (US06373033-20020416-M00035.png) 1981-02-20
DK158346B (da) 1990-05-07
CH637927A5 (fr) 1983-08-31
FR2415099A1 (fr) 1979-08-17
HK12184A (en) 1984-02-24
LU80786A1 (fr) 1979-09-07
GB2012765B (en) 1982-09-08
IE47798B1 (en) 1984-06-27
JPS6049192B2 (ja) 1985-10-31
FI790182A (fi) 1979-07-21
PL212899A1 (US06373033-20020416-M00035.png) 1980-01-14
BG31497A3 (en) 1982-01-15
IE790092L (en) 1979-07-20
GB2012765A (en) 1979-08-01
ES477782A1 (es) 1979-09-16
AT377977B (de) 1985-05-28
GB2083458A (en) 1982-03-24
NL191707C (nl) 1996-04-02
DE2901181A1 (de) 1979-07-26
MC1232A1 (fr) 1979-10-26
ES476755A1 (es) 1979-06-01

Similar Documents

Publication Publication Date Title
AU3898778A (US06373033-20020416-M00035.png)
AU73950S (US06373033-20020416-M00035.png)
BG26333A1 (US06373033-20020416-M00035.png)
BG25917A1 (US06373033-20020416-M00035.png)
BE871570A (US06373033-20020416-M00035.png)
BG25806A1 (US06373033-20020416-M00035.png)
BG25814A2 (US06373033-20020416-M00035.png)
BG25816A1 (US06373033-20020416-M00035.png)
BG25818A1 (US06373033-20020416-M00035.png)
BG25835A1 (US06373033-20020416-M00035.png)
BG25836A1 (US06373033-20020416-M00035.png)
BG25842A1 (US06373033-20020416-M00035.png)
BG25843A1 (US06373033-20020416-M00035.png)
BG25849A1 (US06373033-20020416-M00035.png)
BG25854A1 (US06373033-20020416-M00035.png)
BG25857A1 (US06373033-20020416-M00035.png)
BG26638A1 (US06373033-20020416-M00035.png)
BG25871A1 (US06373033-20020416-M00035.png)
BG25872A1 (US06373033-20020416-M00035.png)
BG25874A1 (US06373033-20020416-M00035.png)
BG25875A1 (US06373033-20020416-M00035.png)
BG25879A1 (US06373033-20020416-M00035.png)
BG25889A1 (US06373033-20020416-M00035.png)
BG25897A1 (US06373033-20020416-M00035.png)
BG25898A1 (US06373033-20020416-M00035.png)